Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in IMVT — Immunovant, Inc.

CIK 1692234 Seattle, WA
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,654,593
+$1,452,272 QoQ
Shares Held
42,943
+427.2% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 226 holders
Holding Since
Sep 2020
14 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. IMVT ranks #97 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in IMVT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,654,593 42,943
2026-03-31 $202,321 8,145
2025-12-31 $182,844 7,193
2025-09-30 $119,013 7,383
2025-06-30 $28,448 1,778
2025-03-31 $28,129 1,646
2024-12-31 $5,518,901 222,806
2024-09-30 $7,170,035 251,492
2024-06-30 $4,625,147 175,195
2024-03-31 $5,697,738 176,346
2023-12-31 $7,452,837 176,901
2023-09-30 $1,554,142 40,483
2020-12-31 $2,076,517 44,956
2020-09-30 $175,950 5,000